Home LiteratureArticle Details
PMID: 25275486 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.

PLoS pathogens ·Vol. 10 ·No. 10 ·2014-10-00 ·Pages e1004415

Tursiella ML, Bowman ER, Wanzeck KC, Throm RE, Liao J, Zhu J, Sample CE

Abstract

Latent infection by Epstein-Barr virus (EBV) is highly associated with the endemic form of Burkitt lymphoma (eBL), which typically limits expression of EBV proteins to EBNA-1 (Latency I). Interestingly, a subset of eBLs maintain a variant program of EBV latency - Wp-restricted latency (Wp-R) - that includes expression of the EBNA-3 proteins (3A, 3B and 3C), in addition to EBNA-1. In xenograft assays, Wp-R BL cell lines were notably more tumorigenic than their counterparts that maintain Latency I, suggesting that the additional latency-associated proteins expressed in Wp-R influence cell proliferation and/or survival. Here, we evaluated the contribution of EBNA-3A. Consistent with the enhanced tumorigenic potential of Wp-R BLs, knockdown of EBNA-3A expression resulted in abrupt cell-cycle arrest in G0/G1 that was concomitant with conversion of retinoblastoma protein (Rb) to its hypophosphorylated state, followed by a loss of Rb protein. Comparable results were seen in EBV-immortalized B lymphoblastoid cell lines (LCLs), consistent with the previous observation that EBNA-3A is essential for sustained growth of these cells. In agreement with the known ability of EBNA-3A and EBNA-3C to cooperatively repress p14(ARF) and p16(INK4a) expression, knockdown of EBNA-3A in LCLs resulted in rapid elevation of p14(ARF) and p16I(NK4a). By contrast, p16(INK4a) was not detectably expressed in Wp-R BL and the low-level expression of p14(ARF) was unchanged by EBNA-3A knockdown. Amongst other G1/S regulatory proteins, only p21(WAF1/CIP1), a potent inducer of G1 arrest, was upregulated following knockdown of EBNA-3A in Wp-R BL Sal cells and LCLs, coincident with hypophosphorylation and destabilization of Rb and growth arrest. Furthermore, knockdown of p21(WAF1/CIP1) expression in Wp-R BL correlated with an increase in cellular proliferation. This novel function of EBNA-3A is distinct from the functions previously described that are shared with EBNA-3C, and likely contributes to the proliferation of Wp-R BL cells and LCLs.

MeSH Terms
Animals Antigens, Viral/metabolism Burkitt Lymphoma/virology Cell Line Cell Proliferation/physiology Cyclin-Dependent Kinase Inhibitor p21/metabolism Cyclin-Dependent Kinases/genetics,metabolism Epstein-Barr Virus Nuclear Antigens/metabolism Humans Mice
Chemicals
Antigens, Viral Cyclin-Dependent Kinase Inhibitor p21 Epstein-Barr Virus Nuclear Antigens lymphocryptovirus nuclear antigen 3A Cyclin-Dependent Kinases EBV-encoded nuclear antigen 1
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Tursiella Melissa L
Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, and the Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States of America.
Bowman Emily R
Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, and the Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States of America.
Wanzeck Keith C
Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Throm Robert E
Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Liao Jason
Department of Public Health Sciences, Pennsylvania State University College of Medicine, and the Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States of America.
Zhu Junjia
Department of Public Health Sciences, Pennsylvania State University College of Medicine, and the Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States of America.
Sample Clare E
Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, and the Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States of America.
References (101)
101 references, click to expand
  1. CDK inhibitors: positive and negative regulators of G1-phase progression.
    Genes Dev. 1999 Jun 15;13(12):1501-12 PMID: 10385618
  2. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10565-9 PMID: 7479841
  3. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.
    Genes Dev. 1998 Aug 1;12(15):2424-33 PMID: 9694806
  4. Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells.
    Oncogene. 1996 Oct 3;13(7):1413-21 PMID: 8875979
  5. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice.
    J Virol. 2000 Feb;74(3):1101-13 PMID: 10627520
  6. p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma.
    Blood. 1998 Mar 1;91(5):1680-7 PMID: 9473234
  7. The EBNA-3 gene family proteins disrupt the G2/M checkpoint.
    Oncogene. 2004 Feb 19;23(7):1342-53 PMID: 14716295
  8. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
    Cell Growth Differ. 1990 Dec;1(12):571-80 PMID: 2288874
  9. Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.
    Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1919-24 PMID: 21245331
  10. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    J Virol. 1990 Jun;64(6):2530-6 PMID: 2159528
  11. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
    Virology. 1994 Dec;205(2):596-602 PMID: 7975264
  12. BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV.
    Nucleic Acids Res. 2012 Aug;40(15):7233-46 PMID: 22584624
  13. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.
    Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4291-6 PMID: 10760295
  14. Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis.
    J Cell Sci. 1999 Jun;112 ( Pt 11):1743-53 PMID: 10318766
  15. Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase.
    J Cell Biol. 1994 Aug;126(4):827-37 PMID: 8051209
  16. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  17. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
    EMBO J. 1998 Sep 1;17(17):5001-14 PMID: 9724636
  18. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.
    Cell. 1998 Mar 20;92(6):713-23 PMID: 9529248
  19. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.
    Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18562-6 PMID: 16352731
  20. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.
    Immunity. 1998 Sep;9(3):405-11 PMID: 9768760
  21. Inhibition of cyclin-dependent kinases by p21.
    Mol Biol Cell. 1995 Apr;6(4):387-400 PMID: 7626805
  22. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.
    J Virol. 1989 Jul;63(7):3109-16 PMID: 2542618
  23. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.
    EMBO J. 1994 Jul 15;13(14):3321-8 PMID: 8045261
  24. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.
    J Virol. 1994 Sep;68(9):5602-12 PMID: 7520093
  25. Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C.
    J Virol. 2001 Aug;75(16):7749-55 PMID: 11462050
  26. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.
    Proc Natl Acad Sci U S A. 1982 Dec;79(24):7824-7 PMID: 6961453
  27. Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines.
    Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):337-42 PMID: 21173222
  28. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.
    Cell. 1998 Mar 20;92(6):725-34 PMID: 9529249
  29. EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis.
    J Immunol. 2005 Sep 1;175(5):2968-73 PMID: 16116183
  30. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
    Oncogene. 2008 Jan 17;27(4):421-33 PMID: 17653091
  31. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    J Virol. 1993 Apr;67(4):2014-25 PMID: 8445720
  32. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
    Genes Dev. 1999 Oct 15;13(20):2658-69 PMID: 10541552
  33. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE.
    Nature. 1994 Sep 22;371(6495):346-7 PMID: 8090205
  34. Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.
    Blood. 2010 Dec 9;116(24):5256-67 PMID: 20829369
  35. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  36. Downregulation of p21(WAF1/CIP1) and estrogen receptor alpha in MCF-7 cells by antisense oligonucleotides containing locked nucleic acid (LNA).
    Oligonucleotides. 2004;14(2):147-56 PMID: 15294077
  37. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
    PLoS Pathog. 2009 Jun;5(6):e1000492 PMID: 19557159
  38. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.
    J Virol. 1994 Sep;68(9):6069-73 PMID: 8057484
  39. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
    Virology. 1987 Sep;160(1):151-61 PMID: 2820125
  40. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site.
    Proc Natl Acad Sci U S A. 1986 Jul;83(14):5096-100 PMID: 3460083
  41. Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2.
    Oncogene. 2003 Oct 16;22(46):7181-91 PMID: 14562046
  42. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Cell Growth Differ. 1996 Dec;7(12):1723-32 PMID: 8959341
  43. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    J Virol. 1991 May;65(5):2545-54 PMID: 1850028
  44. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14935-40 PMID: 17001014
  45. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.
    J Virol. 1987 Dec;61(12):3672-9 PMID: 2824806
  46. p21-containing cyclin kinases exist in both active and inactive states.
    Genes Dev. 1994 Aug 1;8(15):1750-8 PMID: 7958854
  47. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.
    Cell. 1995 Aug 25;82(4):675-84 PMID: 7664346
  48. Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma.
    Mol Cell Biol. 1999 Mar;19(3):1651-60 PMID: 10022853
  49. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  50. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
    Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8292-7 PMID: 9653180
  51. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
    J Virol. 2010 Mar;84(6):2893-901 PMID: 20042495
  52. Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.
    Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19500-5 PMID: 17159137
  53. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.
    EMBO J. 1996 Jun 3;15(11):2748-59 PMID: 8654372
  54. The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.
    J Biol Chem. 2004 Dec 17;279(51):53317-22 PMID: 15485814
  55. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
    Semin Cancer Biol. 2009 Dec;19(6):377-88 PMID: 19619657
  56. Lamin proteolysis facilitates nuclear events during apoptosis.
    J Cell Biol. 1996 Dec;135(6 Pt 1):1441-55 PMID: 8978814
  57. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.
    Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5515-20 PMID: 11960009
  58. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes.
    J Virol. 1996 Jun;70(6):4179-83 PMID: 8648764
  59. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.
    J Virol. 2007 Jan;81(1):248-60 PMID: 17035311
  60. p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.
    Oncogene. 2007 Oct 18;26(48):6954-8 PMID: 17486059
  61. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
    J Virol. 1996 Jan;70(1):623-7 PMID: 8523583
  62. A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes.
    J Virol. 1988 Apr;62(4):1330-8 PMID: 2831394
  63. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
    J Virol. 2006 Nov;80(22):11200-8 PMID: 16956945
  64. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
    PLoS Pathog. 2010 Jun 10;6(6):e1000951 PMID: 20548956
  65. Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth.
    J Virol. 2003 Oct;77(19):10437-47 PMID: 12970429
  66. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
    Proc Natl Acad Sci U S A. 1990 Mar;87(5):1725-9 PMID: 2155423
  67. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.
    Proc Natl Acad Sci U S A. 1982 Dec;79(24):7837-41 PMID: 6818551
  68. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
    Nature. 1984 Jul 19-25;310(5974):207-11 PMID: 6087149
  69. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.
    Nature. 1993 Dec 16;366(6456):707-10 PMID: 8259216
  70. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  71. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53.
    EMBO J. 1995 Apr 3;14(7):1382-91 PMID: 7729416
  72. Cdc25 cell-cycle phosphatase as a target of c-myc.
    Nature. 1996 Aug 8;382(6591):511-7 PMID: 8700224
  73. New functional activities for the p21 family of CDK inhibitors.
    Genes Dev. 1997 Apr 1;11(7):847-62 PMID: 9106657
  74. PUMA, a novel proapoptotic gene, is induced by p53.
    Mol Cell. 2001 Mar;7(3):683-94 PMID: 11463392
  75. Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5.
    J Cell Biol. 2003 Jul 21;162(2):173-83 PMID: 12860972
  76. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro.
    J Virol. 1992 May;66(5):2893-903 PMID: 1313908
  77. MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.
    Mol Cell. 2005 Dec 9;20(5):699-708 PMID: 16337594
  78. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Oncogene. 1992 Sep;7(9):1775-82 PMID: 1354347
  79. Lymphomas differ in their dependence on Epstein-Barr virus.
    Blood. 2011 Feb 10;117(6):1977-85 PMID: 21088132
  80. Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes.
    Proc Natl Acad Sci U S A. 1988 Jun;85(11):3678-82 PMID: 2836854
  81. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis.
    EMBO J. 1996 Dec 16;15(24):6969-78 PMID: 9003773
  82. African Burkitt's lymphoma. History, biology, clinical features, and treatment.
    Am J Pediatr Hematol Oncol. 1991 Summer;13(2):222-46 PMID: 2069232
  83. Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP).
    J Biol Chem. 2002 Dec 6;277(49):47197-204 PMID: 12372828
  84. mdm2 expression is induced by wild type p53 activity.
    EMBO J. 1993 Feb;12(2):461-8 PMID: 8440237
  85. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
    Oncogene. 1991 Oct;6(10):1915-22 PMID: 1923514
  86. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2.
    J Virol. 1999 May;73(5):4481-4 PMID: 10196351
  87. Modulation of p53 expression using antisense oligonucleotides complementary to the 5'-terminal region of p53 mRNA in vitro and in the living cells.
    PLoS One. 2013 Nov 11;8(11):e78863 PMID: 24244378
  88. The pathogenesis of Burkitt's lymphoma.
    Adv Cancer Res. 1990;55:133-270 PMID: 2166998
  89. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Nat Med. 2002 Oct;8(10):1098-104 PMID: 12219084
  90. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
    J Virol. 2009 May;83(9):4652-69 PMID: 19244339
  91. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  92. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
    PLoS Pathog. 2013 Feb;9(2):e1003187 PMID: 23436997
  93. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.
    EMBO J. 1999 Mar 15;18(6):1571-83 PMID: 10075928
  94. A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.
    J Virol. 1987 Nov;61(11):3424-30 PMID: 2822952
  95. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
    PLoS Pathog. 2009 Mar;5(3):e1000341 PMID: 19283066
  96. BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.
    Proc Natl Acad Sci U S A. 1988 Feb;85(4):995-9 PMID: 2829223
  97. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.
    J Virol. 1996 Jul;70(7):4228-36 PMID: 8676443
  98. p21 is a universal inhibitor of cyclin kinases.
    Nature. 1993 Dec 16;366(6456):701-4 PMID: 8259214
  99. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    J Virol. 2000 Jun;74(11):5151-60 PMID: 10799590
  100. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
    EMBO J. 1987 Sep;6(9):2743-51 PMID: 2824192
  101. Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.
    PLoS Pathog. 2009 Jul;5(7):e1000506 PMID: 19578441
Article Info
Journal
PLoS pathogens
Abbr.
PLoS Pathog
ISSN
1553-7374
Published
2014-10-00
Epub
2014-00-02
Pages
e1004415
Language
English
Region
United States
NLM ID
101238921
PMCID
PMC4183747
Subset
IM
Grants
NCI NIH HHS · R01 CA117827 · United States
NCI NIH HHS · CA21765 · United States
NCI NIH HHS · T32 CA060395 · United States
NCI NIH HHS · P30 CA021765 · United States
NCI NIH HHS · CA117827 · United States
NCI NIH HHS · 5T32 CA60395 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com